ANDA 78126, held by Apotex Inc. Fosphenytoin Sodium.
As of Nov 16, 2026, ANDA 78126 (Fosphenytoin Sodium), held by Apotex Inc, was first approved by FDA on Aug 6, 2007, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 6, 2007 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fosphenytoin SodiumEQ 50MG PHENYTOIN NA/ML · injectable;injection | Fosphenytoin Sodium | Discontinued |
| Aug 1, 2022 | Supplement 13Labeling · Standard review | Approved | None posted |
| Aug 1, 2022 | Supplement 14Labeling · Standard review | Approved | None posted |
| Aug 1, 2022 | Supplement 15Labeling · Standard review | Approved | None posted |
| Aug 1, 2022 | Supplement 16Labeling · Standard review | Approved | None posted |
| Oct 3, 2019 | Supplement 11Labeling · Standard review | Approved | None posted |
| Oct 3, 2019 | Supplement 12Labeling · Standard review | Approved | None posted |
| Oct 31, 2017 | Supplement 9Labeling · Standard review | Approved | None posted |
| Oct 31, 2017 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jun 24, 2016 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jun 24, 2016 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jun 24, 2016 | Supplement 7Labeling · Standard review | Approved | None posted |
| Jun 24, 2016 | Supplement 8Labeling · Standard review | Approved | None posted |
| Aug 6, 2007 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters